Home›People›Kristie Grebe
KG

Kristie Grebe

Executive officer at Navigator Medicines.

Executive
Updated Nov 9, 2026·Latest SEC filing Sep 25, 2026·Suggest an edit

About Kristie Grebe

Kristie Grebe is an executive officer at Navigator Medicines.

Experience

This experience comes from Kristie Grebe's profile and from SEC filings. For roles taken from filings, the years are when the filings name Kristie Grebe in the role, so the role may have started earlier or lasted longer.

Navigator Medicines, Inc. Current
CSO/Head of R&D
2025 – Present · San Mateo, CA
Develops antibody treatments for people with inflammatory and autoimmune diseases.
Anokion
Chief Scientific Officer
2019 – 2025
AbbVie
Associate Scientific Director
2008 – 2019
Abbott Bioresearch Center
Sr Scientist II
2010 – 2012
National Institutes of Health
Postdoctoral Fellow
2005 – 2008
National Jewish Health
Predoctoral Fellow
2000 – 2004
University of Florida
Lab Technician
1997 – 1999

Key Colleagues at Startups

The people Kristie Grebe works with at each company, as listed on that company's latest Form D.

Navigator Medicines, Inc. · Form D, Sep 25, 2026
ST
Stephen Thomas
Co-Founder and CEO, Sera Medicine, director
MV
SF
Scott Forrest
Chief Financial Officer
TB
Tausif Butt
CEO and President, director
KF
Khurem Farooq
Board Chair
WJ

Sources

  1. SECNavigator Medicines, Inc. Form D, filed Sep 25, 2026